Pomalidomide Grindeks

Medicinal product

(Invented) name

Pomalidomide Grindeks

Active substance (s)

Pomalidomidas

Strength

4 mg

Pharmaceutical form

kietosios kapsulės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

L04AX06, Pomalidomide

Marketing authorisation holder

AS GRINDEKS, Latvija

Date of authorisation

2024-11-21

Date of renewal

Documents

Pomalidomide Grindeks mokomoji medziaga sveikatos prieziuros specialistams.pdf

5639_5642 Pakuotės lapelis 2025 04 25.docx

Pomalidomide Grindeks mokomoji medziaga pacientams.pdf

5639_5642 Pomalidomide Grindeks RPP 2025 04 25.docx

Pomalidomide Grindeks informavimo apie rizika forma.pdf

Pomalidomide Grindeks paciento kortele.pdf

Pomalidomide Grindeks informavimo apie nestuma forma.pdf

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

10(1)

Procedure number

SE/H/2464/004/DC

Marketing authorisation procedure

Decentralizuota procedūra

Qualitative and quantitative composition

Kapsulėje yra	1 vnt.
Pomalidomidas	4 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
115772	101875	1101875	lizdinė plokštelė	N21		Receptinis	LT/1/24/5642/001	Tiekiama	2025-06-30	-	No	-	-
117495	103598	1103598	lizdinė plokštelė	N14		Receptinis	LT/1/24/5642/002	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2024-11-21	Registruotas